Association of the C-Reactive Protein-Triglyceride Glucose Index with Coronary Severity and Incident Heart Failure in Newly Diagnosed Coronary Artery Disease
In a retrospective cohort of 813 patients with newly diagnosed coronary artery disease, the C-reactive protein–triglyceride glucose (CTI) index was significantly associated with both coronary lesion severity and an increased risk of incident heart failure, demonstrating robust predictive value and suggesting its utility as a cost-effective tool for risk stratification.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Heart disease is often thought of as a plumbing problem, a matter of clogged pipes that need clearing. But for the millions of people diagnosed with coronary artery disease, the story does not end when a blockage is found or a stent is placed. For many, the heart muscle itself begins to weaken over time, a slow deterioration that can lead to heart failure, a condition where the heart struggles to pump enough blood to sustain the body. While doctors have long known that inflammation and metabolic issues like high blood sugar and fat play a role in this decline, they have struggled to find a simple way to measure the combined weight of these forces in a single patient. Inflammation is the body's fire, and metabolic dysfunction is the fuel; when they burn together, they can accelerate damage in ways that looking at them separately might miss.
A team of researchers at the First Affiliated Hospital of Fujian Medical University set out to see if they could capture this combined risk using a tool they call the C-reactive protein–triglyceride glucose index. This index is not a new machine or a complex genetic test; it is a calculation derived from standard blood tests that almost every hospital already performs. It takes a measure of inflammation, known as C-reactive protein, and blends it with measures of blood sugar and triglycerides, a type of fat in the blood. The researchers wanted to know if this single number could tell them two critical things about patients who had just been diagnosed with coronary artery disease for the first time: how severe the blockages in their heart arteries were, and how likely they were to develop heart failure in the years following their diagnosis.
To find the answer, the team looked back at the medical records of 813 patients who had undergone heart catheterization between 2020 and 2025. These were people who had never had a heart attack or heart surgery before, making their diagnosis a fresh starting point. The researchers calculated the index for each patient and then watched what happened over a median period of 37 months. They also measured the severity of the artery blockages using a scoring system known as the Gensini score, which assigns higher numbers to more extensive and severe disease. The results showed a clear and non-linear connection: as the index value rose, the severity of the artery blockages increased, but not in a straight, steady line. Instead, the relationship accelerated, suggesting that once a certain threshold of combined inflammation and metabolic stress is crossed, the damage to the arteries compounds more rapidly.
The most significant finding, however, concerned the future health of the heart muscle itself. Over the course of the study, 64 patients, or nearly 8 percent of the group, developed new-onset heart failure. The risk was not evenly distributed. Patients with the highest index values were far more likely to develop heart failure than those with lower values. Even after the researchers adjusted for other known risk factors like age, gender, diabetes, and high blood pressure, the index remained a powerful predictor. For every single unit increase in the index, the risk of developing heart failure more than doubled. This association held true even when the researchers accounted for how well the heart was pumping at the start of the study, suggesting that the index captures a risk that exists independently of the heart's current strength.
The researchers also tested whether this index was better at predicting heart failure than looking at its individual parts or other common markers. They found that the index performed just as well as the inflammation marker alone and significantly better than a similar index that only looked at blood sugar and fat. This suggests that combining the two pathways—fire and fuel—provides a clearer picture of the risk than looking at either one in isolation. The study also explored why this might be happening. They found that the index was linked to heart failure partly because it was associated with more severe artery blockages and partly because it was linked to higher pressures inside the heart's filling chambers. However, the researchers noted that these connections were exploratory and that the index itself is not a direct cause of the disease, but rather a signpost pointing to a dangerous metabolic state.
While the study was limited to a single hospital and relied on past records, the consistency of the results across different groups of patients gave the findings weight. The index worked similarly for men and women, for older and younger patients, and for those with or without diabetes. The researchers concluded that this simple calculation, which adds virtually no cost to a standard medical visit, could help doctors identify patients with newly diagnosed heart disease who are at the highest risk of future heart failure. These are the patients who might need closer monitoring and more aggressive management of their inflammation and metabolism. The study does not claim that the index is a magic bullet or a replacement for existing treatments, but it does offer a practical, low-cost way to see the hidden danger lurking in the combination of inflammation and metabolic stress, potentially helping to prevent the slow slide into heart failure before it begins.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.